Atherosclerosis Atlas Sheds Light on Heart Attacks and Strokes
University of Virginia (UVA) School of Medicine researchers have created an atlas of atherosclerosis that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart...
USDA Grant Awarded to Create South Florida Microbiome Innovation Center
Florida Atlantic University (FAU), in collaboration with Florida International University (FIU), has received a four-year, $1 million grant from the United States Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to...
Gavi commits more than US$1.8 billion to support vaccine production in Africa
Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move that could bolster the continent’s efforts to address historical dependence on imported vaccines and...
Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs
Insights from IndustryDr. Rajas V. WarkeDirector of Molecular Biology & Virology HiMedia Labs Join us in an engaging interview with Dr. Rajas Warke, Director of Molecular Biology and Virology at HiMedia Labs. Dr. Warke plays a...
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and which aims to accelerate wound debridement and contribute to wound bed preparation & healing,...
In a new light – new approach overcomes long-standing limitations in optics
Osaka, Japan – When you look up at the sky and see clouds of wondrous shapes, or struggle to peer through dense, hazy fog, you’re seeing the results of ‘Mie scattering’, which is what...
Landscape for AML patients evolving rapidly as research discoveries advance new treatments
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 10, 2023, AT 7:30 P.M. ET) – The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University...
ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare...
SAN DIEGO ― The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results...
Tracing how the infant brain responds to touch with near-infrared spectroscopy
Tokyo, Japan – Researchers from Tokyo Metropolitan University have measured how oxygenated hemoglobin levels in the blood change in infants’ brains in response to touch. Using spectroscopy methods with external sensors placed on the...
MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers....
